JP2007532511A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532511A5
JP2007532511A5 JP2007506736A JP2007506736A JP2007532511A5 JP 2007532511 A5 JP2007532511 A5 JP 2007532511A5 JP 2007506736 A JP2007506736 A JP 2007506736A JP 2007506736 A JP2007506736 A JP 2007506736A JP 2007532511 A5 JP2007532511 A5 JP 2007532511A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
acceptable salt
solvate
physiologically functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007506736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/003722 external-priority patent/WO2005097076A2/en
Publication of JP2007532511A publication Critical patent/JP2007532511A/ja
Publication of JP2007532511A5 publication Critical patent/JP2007532511A5/ja
Pending legal-status Critical Current

Links

JP2007506736A 2004-04-09 2005-04-07 低用量医薬品 Pending JP2007532511A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56123504P 2004-04-09 2004-04-09
PCT/EP2005/003722 WO2005097076A2 (en) 2004-04-09 2005-04-07 Low dose pharmaceutical products

Publications (2)

Publication Number Publication Date
JP2007532511A JP2007532511A (ja) 2007-11-15
JP2007532511A5 true JP2007532511A5 (cg-RX-API-DMAC7.html) 2008-05-01

Family

ID=34963972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506736A Pending JP2007532511A (ja) 2004-04-09 2005-04-07 低用量医薬品

Country Status (4)

Country Link
US (1) US20070202179A1 (cg-RX-API-DMAC7.html)
EP (1) EP1734930A2 (cg-RX-API-DMAC7.html)
JP (1) JP2007532511A (cg-RX-API-DMAC7.html)
WO (1) WO2005097076A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
AR065802A1 (es) * 2007-03-22 2009-07-01 Schering Corp Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
SG178880A1 (en) 2009-08-26 2012-04-27 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2389927A1 (en) * 2010-05-30 2011-11-30 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of rasagiline
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014084921A1 (en) * 2012-11-27 2014-06-05 Rose Stuart Pharmaceutical manufacturing method and compositions
BR112021002207A2 (pt) 2018-08-10 2021-05-04 Diapin Therapeutics, Llc tri-peptídeos e tratamento de distúrbios metabólicos, cardiovasculares e inflamatórios

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
EP0782449B1 (en) * 1994-09-22 2003-04-09 Akzo Nobel N.V. Process of making dosage units by wet granulation
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
ATE243500T1 (de) * 1996-04-04 2003-07-15 Felix Specht Verfahren zur herstellung von gering dosierten freifliessenden und/oder direktkomprimierbaren pulversystemen
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0113232D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical process

Similar Documents

Publication Publication Date Title
JP6456849B2 (ja) 高められた性能及び改善された加工性を有する医薬組成物
CZ298489B6 (cs) Prášek pro použití v inhalátoru
KR101052693B1 (ko) 건조 분말 흡입용 조성물의 제조방법
CN106265641B (zh) 一种含有维格列汀和二甲双胍的药物组合物及其制备方法
TW201117838A (en) (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
EP1928427B1 (en) Novel dosage formulation
JP2007532511A (ja) 低用量医薬品
JP2024535134A5 (cg-RX-API-DMAC7.html)
JP7419333B2 (ja) メタ亜ヒ酸塩を含む医薬組成物および製造方法
EP3466939B1 (en) New dapagliflozin crystal form and preparation method and use thereof
TW201114422A (en) Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same
WO2022193723A1 (zh) 一种组合物及其制备方法和用途
CA2566161C (en) Aryl ketone compounds and compositions for delivering active agents
WO2021136507A1 (zh) 一种二肽基肽酶4抑制剂的药物组合物及其制备方法和应用
WO2010054533A1 (zh) 一种盐酸赛庚啶乳膏剂及其制备方法
TW202028194A (zh) 呋喹替尼製劑及其應用
WO2009111947A1 (zh) 结晶型1-（3-氟苯基）-5-甲基-2-（1h）吡啶酮、其制备方法、及其组合物和应用
CN1678292A (zh) 用于形成缓释剂型中可膨胀性渗透组合物的涂料悬浮液(包含渗透聚合物、渗透剂)以及提供该渗透涂料的相应方法
JP7478839B2 (ja) 固形医薬製剤、並びにその製造方法及び使用
CN110585155A (zh) 一种格列齐特片（ii）及其制备方法
CN104644587A (zh) 一种治疗心血管疾病的药物组合物的制备方法
CN103349652B (zh) 含有四氢萘酰胺化合物或其可药用盐的高药物载荷片剂
WO2020246528A1 (ja) 痛風又は高尿酸血症の治療薬
CN103908437B (zh) 一种苯扎贝特缓释制剂及其制备方法
CN1768751A (zh) 酚麻美愈分散片的制备方法